Correlation Between Novo Nordisk and Ultragenyx
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Ultragenyx, you can compare the effects of market volatilities on Novo Nordisk and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Ultragenyx.
Diversification Opportunities for Novo Nordisk and Ultragenyx
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Novo and Ultragenyx is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Ultragenyx go up and down completely randomly.
Pair Corralation between Novo Nordisk and Ultragenyx
Considering the 90-day investment horizon Novo Nordisk AS is expected to under-perform the Ultragenyx. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 1.34 times less risky than Ultragenyx. The stock trades about -0.24 of its potential returns per unit of risk. The Ultragenyx is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest 5,522 in Ultragenyx on August 27, 2024 and sell it today you would lose (810.00) from holding Ultragenyx or give up 14.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Ultragenyx
Performance |
| Timeline |
| Novo Nordisk AS |
| Ultragenyx |
Novo Nordisk and Ultragenyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Ultragenyx
The main advantage of trading using opposite Novo Nordisk and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |